A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab. (Record no. 23175387)

MARC details
000 -LEADER
fixed length control field 02530 a2200649 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516174304.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201407s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1557-3265
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1158/1078-0432.CCR-13-1120
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Press, Oliver W
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20140714
245 00 - TITLE STATEMENT
Title A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical cancer research : an official journal of the American Association for Cancer Research
Date of publication, distribution, etc. Dec 2013
300 ## - PHYSICAL DESCRIPTION
Extent 6624-32 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Murine-Derived
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials, Phase III as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclophosphamide
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Doxorubicin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hemoglobins
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kaplan-Meier Estimate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymph Nodes
General subdivision pathology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoma, Follicular
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Multivariate Analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Organ Size
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prednisone
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proportional Hazards Models
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rituximab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vincristine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Young Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element beta 2-Microglobulin
General subdivision blood
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Unger, Joseph M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rimsza, Lisa M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Friedberg, Jonathan W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name LeBlanc, Michael
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Czuczman, Myron S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kaminski, Mark
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Braziel, Rita M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Spier, Catherine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gopal, Ajay K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Maloney, David G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cheson, Bruce D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dakhil, Shaker R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Miller, Thomas P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fisher, Richard I
773 0# - HOST ITEM ENTRY
Title Clinical cancer research : an official journal of the American Association for Cancer Research
Related parts vol. 19
-- no. 23
-- p. 6624-32
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1158/1078-0432.CCR-13-1120">https://doi.org/10.1158/1078-0432.CCR-13-1120</a>
Public note Available from publisher's website

No items available.